ACADIAN ASSET MANAGEMENT LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$109
-100.0%
3,073
-84.9%
0.00%
-100.0%
Q3 2022$898,000
+739.3%
20,390
+757.4%
0.01%
Q1 2021$107,000
-94.5%
2,378
-93.1%
0.00%
-100.0%
Q4 2020$1,946,000
+63.0%
34,404
+36.8%
0.01%
+60.0%
Q3 2020$1,194,000
-65.4%
25,157
-57.0%
0.01%
-66.7%
Q2 2020$3,452,000
+6538.5%
58,523
+5205.8%
0.02%
Q1 2020$52,000
-71.4%
1,103
-63.4%
0.00%
-100.0%
Q4 2019$182,000
+193.5%
3,010
+212.6%
0.00%
Q2 2019$62,000
-18.4%
963
+2.6%
0.00%
Q1 2019$76,000
-63.3%
939
-75.5%
0.00%
-100.0%
Q4 2018$207,000
+2487.5%
3,828
+2322.8%
0.00%
Q3 2018$8,000
+14.3%
1580.0%0.00%
Q2 2018$7,000
+250.0%
158
+229.2%
0.00%
Q1 2018$2,000
-98.6%
48
-98.3%
0.00%
-100.0%
Q4 2017$143,000
-16.4%
2,829
-16.3%
0.00%0.0%
Q3 2017$171,000
+2750.0%
3,380
+2263.6%
0.00%
Q1 2017$6,000
-25.0%
143
+6.7%
0.00%
Q4 2015$8,0001340.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders